All In Biotech

Free tool

FAERS Monitor: Pulmicort Respules

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020929 or its brand name (Pulmicort Respules, Budesonide). Reports on generic versions are filed under their own applications.

Reports

42,547

Serious

32,411

76% of reports

Hospitalization

15,678

Death reported

3,177

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective4,994
  • dyspnoea4,876
  • off label use4,639
  • asthma3,791
  • fatigue2,641
  • condition aggravated2,522
  • headache2,477
  • diarrhoea2,412
  • cough2,387
  • pneumonia2,319
  • nausea2,151
  • wheezing2,124
  • pyrexia1,942
  • pain1,893
  • weight decreased1,753

Reports by year received

View as table
YearReports
2004161
2005230
2006219
2007434
2008576
2009570
2010549
2011563
2012822
2013840
20141,041
20151,402
20161,632
20171,742
20182,306
20193,015
20203,624
20213,765
20224,013
20233,995
20244,143
20254,049
20262,856

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,011,612 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
wheezingSignal2,12418.317.633,625
asthmaSignal3,79117.116.655,908
dyspnoeaSignal4,8764.34.212,513
coughSignal2,3874.24.15,925
condition aggravatedSignal2,5224.14.06,009
pneumoniaSignal2,3193.63.44,300
weight decreasedSignal1,7533.13.02,537
pyrexiaSignal1,9422.82.72,244
off label useSignal4,6392.62.64,853
headache2,4772.01.91,189
drug ineffective4,9941.91.82,172
diarrhoea2,4121.91.8968
fatigue2,6411.71.6750
pain1,8931.51.5351
nausea2,1511.31.3196

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.